Sofinnova is a leading biotech investment firm that supports the development and growth of transformative biotech companies. With a collaborative approach and extensive experience, Sofinnova guides entrepreneurs through every phase of their journey, from drug development and regulatory processes to company building and IPO. With a portfolio of over 110 funded companies, 52 IPOs, and 27 FDA-approved drugs, Sofinnova is committed to advancing medical care and improving lives through innovative science and entrepreneurship.
By deploying human and financial capital, Sofinnova brings together the worlds of life science, finance, and innovation to turn dreams into drugs. With a focus on binding science and innovation, Sofinnova partners with world-class entrepreneurs who are dedicated to transforming medicine and challenging the status quo of medical care. With their expertise and resources, Sofinnova empowers these entrepreneurs to advance cures and make a transformative impact on the healthcare industry.
Generated from the website